The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients

Creative Commons License

Yazısız V., Yılmaz V. T., Uçar İ., Dandin Ö., Aslan B., Erbasan F., ...Daha Fazla

ARCHIVES OF RHEUMATOLOGY, cilt.36, sa.3, ss.366-374, 2021 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.46497/archrheumatol.2021.8500
  • Dergi Adı: ARCHIVES OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.366-374
  • Anahtar Kelimeler: Amyloidosis, anti-interleukin-1, familial Mediterranean fever, inhibitors, kidney, transplantation, tumor necrosis factor-alpha, FAMILIAL MEDITERRANEAN FEVER, COLCHICINE, RESISTANT, ANAKINRA, DISEASE
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objectives: The aim of this study was to investigate the efficacy and safety of anti-interleukin-1 (anti-IL-1) agents and tumor necrosis factor-alpha (TNF-alpha) inhibitors in renal transplant patients.